Truist analyst David MacDonald raised the firm’s price target on Ensign Group to $125 from $110 and keeps a Hold rating on the shares as part of a broader research note and outlook for FY24 among Healthcare Services names. Truist remains “broadly constructive” on core fundamentals across the group given “brisk sector tailwinds” around demand, the move to value-based care, and demographics, along with the group’s attractive positioning within segments and robust cash generation. The firm also notes that financial flexibility across much of the group should continue to underpin strong growth investment, M&A, and shareholder value creation, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ENSG:
- The Ensign Group Acquires Skilled Nursing Facility in Nevada
- The Ensign Group Acquires Skilled Nursing Facility in Tennessee
- Ensign Group acquires skilled nursing facilities in Tennessee, Nevada
- The Ensign Group, Inc. Increases Quarterly Dividend to $0.06 Per Share
- Ensign Group raises quarterly dividend to 6c per share